Skip to main content
Log in

Nitro-Oleic Acid Prevents Hypoxia- and Asymmetric Dimethylarginine-Induced Pulmonary Endothelial Dysfunction

  • ORIGINAL ARTICLE
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Rationale

Pulmonary hypertension (PH) represents a serious health complication accompanied with hypoxic conditions, elevated levels of asymmetric dimethylarginine (ADMA), and overall dysfunction of pulmonary vascular endothelium. Since the prevention strategies for treatment of PH remain largely unknown, our study aimed to explore the effect of nitro-oleic acid (OA-NO2), an exemplary nitro-fatty acid (NO2-FA), in human pulmonary artery endothelial cells (HPAEC) under the influence of hypoxia or ADMA.

Methods

HPAEC were treated with OA-NO2 in the absence or presence of hypoxia and ADMA. The production of nitric oxide (NO) and interleukin-6 (IL-6) was monitored using the Griess method and ELISA, respectively. The expression or activation of different proteins (signal transducer and activator of transcription 3, STAT3; hypoxia inducible factor 1α, HIF-1α; endothelial nitric oxide synthase, eNOS; intercellular adhesion molecule-1, ICAM-1) was assessed by the Western blot technique.

Results

We discovered that OA-NO2 prevents development of endothelial dysfunction induced by either hypoxia or ADMA. OA-NO2 preserves normal cellular functions in HPAEC by increasing NO production and eNOS expression. Additionally, OA-NO2 inhibits IL-6 production as well as ICAM-1 expression, elevated by hypoxia and ADMA. Importantly, the effect of OA-NO2 is accompanied by prevention of STAT3 activation and HIF-1α stabilization.

Conclusion

In summary, OA-NO2 eliminates the manifestation of hypoxia- and ADMA-mediated endothelial dysfunction in HPAEC via the STAT3/HIF-1α cascade. Importantly, our study is bringing a new perspective on molecular mechanisms of NO2-FAs action in pulmonary endothelial dysfunction, which represents a causal link in progression of PH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Resp Crit Care. 2008;177:108–13.

    Article  Google Scholar 

  2. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8:443–55.

    Article  CAS  PubMed  Google Scholar 

  3. Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF. Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease. Eur Respir J. 2012;39:112–8.

    Article  CAS  PubMed  Google Scholar 

  4. Sanli C, Oguz D, Olgunturk R, et al. Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease. Pediatr Cardiol. 2012;33:1323–31.

    Article  PubMed  Google Scholar 

  5. Lüneburg N, Harbaum L, Hennigs JK. The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases. Biomed Res Int. 2014.

  6. Parikh RV, Scherzer R, Nitta EM, et al. Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. AIDS. 2014;28:511–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Trittmann JK, Peterson E, Rogers LK, et al. Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr. 2015;166:230–3.

    Article  CAS  PubMed  Google Scholar 

  8. Iannone L, Zhao L, Dubois O, et al. miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia. Biochem J. 2014;462:103–12.

    Article  CAS  PubMed  Google Scholar 

  9. Pekarova M, Koudelka A, Kolarova H, et al. Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha. Vasc Pharmacol. 2015;73:138–48.

    Article  CAS  Google Scholar 

  10. Rudolph TK, Rudolph V, Edreira MM, et al. Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice. Arterioscl Throm Vas. 2010;30:938–45.

    Article  CAS  Google Scholar 

  11. Rudolph V, Rudolph TK, Schopfer FJ, et al. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res. 2010;85:155–66.

    Article  CAS  PubMed  Google Scholar 

  12. Khoo NK, Rudolph V, Cole MP, et al. Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids. Free Radic Biol Med. 2010;48:230–9.

    Article  CAS  PubMed  Google Scholar 

  13. Zhang J, Villacorta L, Chang L, et al. Nitro-oleic acid inhibits angiotensin II–induced hypertension. Circ Res. 2010;107:540–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kansanen E, Jyrkkänen HK, Volger OL, et al. Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid. J Biol Chem. 2009;284:33233–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Schopfer FJ, Cole MP, Groeger AL, et al. Covalent peroxisome proliferator-activated receptor{gamma} binding by nitro-fatty acids: endogenous ligands act as selective modulators. J Biol Chem. 2010;285:12321–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Klinke A, Möller A, Pekarova M, et al. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension. Am J Resp Cell Mol. 2014;51:155–62.

    Article  Google Scholar 

  17. Yang XP, Irani K, Mattagajasingh S, et al. Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium. Arterioscl Throm Vasc. 2005;25:1395–400.

    Article  CAS  Google Scholar 

  18. Paulin R, Meloche J, Bonnet S. STAT3 signaling in pulmonary arterial hypertension. JAK-STAT. 2012;1:223–33.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sun CK, Zhen YY, Lu HI, Sung PH, et al. Reducing TRPC1 expression through liposome-mediated siRNA delivery markedly attenuates hypoxia-induced pulmonary arterial hypertension in a murine model. Stem Cells Int. 2014;2014:316214.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ambrozova G, Martiskova H, Koudelka A, et al. Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses. Free radical bio med. 2016; 90:252-60.Lim DG, Sweeney S, Bloodsworth a, et al. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. P Natl Acad Sci USA. 2002;99:15941–6.

    Article  Google Scholar 

  21. Lima ES, Bonini MG, Augusto O, Barbeiro HV, Souza HP, Abdalla DS. Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Radic Biol Med. 2005;39:532–9.

    Article  CAS  PubMed  Google Scholar 

  22. Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, d’Ischia M. Nitro-fatty acid formation and signaling. J Biol Chem. 2008;283:15515–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Shin E, Yeo E, Lim J, et al. Nitrooleate mediates nitric oxide synthase activation in endothelial cells. Lipids. 2014;49:457–66.

    Article  CAS  PubMed  Google Scholar 

  24. Wang H, Jia Z, Sun J, et al. Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade. Mediat Inflamm 2015.

  25. Balazy M, Iesaki T, Park JL, et al. Vicinal nitrohydroxyeicosatrienoic acids: vasodilator lipids formed by reaction of nitrogen dioxide with arachidonic acid. J Pharmacol Exp Ther. 2001;299:611–9.

    CAS  PubMed  Google Scholar 

  26. Schopfer FJ, Baker PR, Giles G, et al. Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J Biol Chem. 2005;280:19289–97.

    Article  CAS  PubMed  Google Scholar 

  27. Ambrozova G, Fidlerova T, Verescakova H, et al. Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition. Biochim Biophys Acta. 2016; pii: S0304–4165(16)30251–30253.

  28. Reddy AT, Lakshmi SP, Dornadula S, Pinni S, Rampa DR, Reddy RC. The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease. J Immunol. 2013;191:2053–63.

    Article  CAS  PubMed  Google Scholar 

  29. Villacorta L, Chang L, Salvatore SR, et al. Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. Cardiovasc Res. 2013;98:116–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Wu Y, Dong Y, Song P, Zou MH. Activation of the AMP-activated protein kinase (AMPK) by nitrated lipids in endothelial cells. PLoS One. 2012.

  31. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675–91.

  32. Rudnicki M, Faine LA, Dehne N, et al. Hypoxia inducible factor-dependent regulation of angiogenesis by nitro-fatty acids. Arterioscl Throm Vasc. 2011;31:1360–7.

  33. Saura M, Zaragoza C, Bao C, Herranz B, Rodriguez-Puyol M, Lowenstein CJ. Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression. J Biol Chem. 2006;281:30057–62.

Download references

Acknowledgments

We would like to thank Jirina Prochazkova, Lenka Svihalkova Sindlerova, and Ondrej Vasicek for a fruitful discussion and insightful suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michaela Pekarova.

Ethics declarations

Funding

This work was supported by the Czech Science Foundation (no. 13-40824P), the Ministry of Education, Youth and Sports (no. LD15069). LK and MP were supported by the European Regional Development Fund, the projects NPS II no. LQ1605 and FNUSA-ICRC no. CZ.1.05/1.1.00/02.0123 from MEYS CR. BAF was supported by NIH grants R01-HL-058115, R01-HL-64937, and PO1-HL-103455.

Conflict of Interest

Bruce A. Freeman (BAF) and Steven R. Woodcock (SRW) acknowledge an interest in Complexa, Inc., as scientific founder/shareholder (BAF) and consultant (SRW). All other authors declare no conflicts of interest with respect to the contents of this manuscript.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Electronic Supplementary Material

ESM 1

(DOCX 1.30 mb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koudelka, A., Ambrozova, G., Klinke, A. et al. Nitro-Oleic Acid Prevents Hypoxia- and Asymmetric Dimethylarginine-Induced Pulmonary Endothelial Dysfunction. Cardiovasc Drugs Ther 30, 579–586 (2016). https://doi.org/10.1007/s10557-016-6700-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-016-6700-3

Keywords

Navigation